Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Acute Lysine Administration on α-aminoadipic Acid
NCT02756117Phase 1Completed
- Sponsor
- Vanderbilt University
- Start
- May 2016
- Primary completion
- Oct 2016
01
Overview
Phase 1, open-label, single-arm trial, sponsored by Vanderbilt University. Primary endpoint: Change in plasma 2-AAA from baseline to peak post-lysine ingestion. Started May 2016; status: completed.
Beyond the preview
Go deeper on NCT02756117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02756117.